Number of Patients, Male	26
Number of Patients, Female	18
Stage	Eligibility required pathologic diagnosis confirming metastatic and unresectable colorectal adenocarcinoma
Age	Median (range): 52 (25–76) years
Number of Prior Systemic Therapies	Median (range): 2 (2–3)
Performance Status: ECOG	0 — 15 1 — 24 2 — 5 3 — 0 Unknown — 0
Other	Primary site of disease: right side, 8; left side, 36. Differentiation of tumors: poor, 4; moderate or well, 30; unknown, 10. Prior targeted therapy: cetuximab, 9; bevacizumab, 29. KRAS/NRAS/BRAF status: KRAS mutation, 23; NRAS mutation, 3; BRAF mutation, 2; Unknown, 7.
Cancer Types or Histologic Subtypes	Colorectal adenocarcinoma, 44